文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

分娩时疟疾测量指标与乌干达高传播地区不良出生结局的关系。

Relationships Between Measures of Malaria at Delivery and Adverse Birth Outcomes in a High-Transmission Area of Uganda.

机构信息

Infectious Diseases Research Collaboration, Kampala, Uganda.

London School of Hygiene and Tropical Medicine, London, United Kingdom.

出版信息

J Infect Dis. 2020 Aug 4;222(5):863-870. doi: 10.1093/infdis/jiaa156.


DOI:10.1093/infdis/jiaa156
PMID:32249917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7399701/
Abstract

BACKGROUND: Clinical trials of interventions for preventing malaria in pregnancy often use measures of malaria at delivery as their primary outcome. Although the objective of these interventions is to improve birth outcomes, data on associations between different measures of malaria at delivery and adverse birth outcomes are limited. METHODS: Data came from 637 Ugandan women enrolled in a randomized controlled trial of intermittent preventive treatment of malaria in pregnancy. Malaria at delivery was detected using peripheral and placental blood microscopy, placental blood loop-mediated isothermal amplification (LAMP), and placental histopathology. Multivariate analyses were used to estimate associations between measures of malaria at delivery and risks of low birth weight (LBW), small for gestational age (SGA), and preterm birth (PTB). RESULTS: Detection of malaria parasites by microscopy or LAMP was not associated with adverse birth outcomes. Presence of malaria pigment detected by histopathology in ≥30% of high-powered fields was strongly associated with LBW (adjusted risk ratio [aRR] = 3.42, P = .02) and SGA (aRR = 4.24, P < .001) but not PTB (aRR = 0.88, P = .87). CONCLUSIONS: A semiquantitative classification system based on histopathologically detected malaria pigment provided the best surrogate measure of adverse birth outcomes in a high-transmission setting and should be considered for use in malaria in pregnancy intervention studies.

摘要

背景:预防妊娠疟疾干预措施的临床试验通常使用分娩时的疟疾测量值作为其主要结局。尽管这些干预措施的目的是改善生育结局,但关于分娩时不同疟疾测量值与不良生育结局之间关联的数据有限。

方法:数据来自于 637 名参加妊娠间歇性预防治疗疟疾随机对照试验的乌干达女性。使用外周血和胎盘血显微镜检查、胎盘血环介导等温扩增(LAMP)和胎盘组织病理学来检测分娩时的疟疾。采用多变量分析来估计分娩时疟疾测量值与低出生体重(LBW)、小于胎龄儿(SGA)和早产(PTB)风险之间的关联。

结果:显微镜或 LAMP 检测到疟原虫与不良生育结局无关。组织病理学检查中≥30%高倍视野中存在疟色素与 LBW(调整风险比[aRR] = 3.42,P =.02)和 SGA(aRR = 4.24,P <.001)强烈相关,但与 PTB 无关(aRR = 0.88,P =.87)。

结论:基于组织病理学检测到的疟色素的半定量分类系统为高传播环境中不良生育结局提供了最佳替代测量值,应考虑在妊娠疟疾干预研究中使用。

相似文献

[1]
Relationships Between Measures of Malaria at Delivery and Adverse Birth Outcomes in a High-Transmission Area of Uganda.

J Infect Dis. 2020-8-4

[2]
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes.

Malar J. 2017-10-5

[3]
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.

Trop Med Int Health. 2014-6-26

[4]
Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.

Afr Health Sci. 2015-9

[5]
Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.

Malar J. 2015-2-7

[6]
An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.

Ann Trop Med Parasitol. 1998-3

[7]
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.

Trans R Soc Trop Med Hyg. 2016-6

[8]
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.

J Infect Dis. 2009-9-15

[9]
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.

Trop Med Int Health. 2009-2

[10]
Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.

Malar J. 2020-4-19

引用本文的文献

[1]
Increased peripartum mortality associated with maternal subclinical malaria in Mozambique.

Malar J. 2023-6-12

[2]
Prenatal malaria exposure and risk of adverse birth outcomes: a prospective cohort study of pregnant women in the Northern Region of Ghana.

BMJ Open. 2022-8-1

[3]
Placental histopathology in preterm birth with confirmed maternal infection: A systematic literature review.

PLoS One. 2021

[4]
Poor Birth Outcomes in Malaria in Pregnancy: Recent Insights Into Mechanisms and Prevention Approaches.

Front Immunol. 2021

[5]
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.

Clin Pharmacol Ther. 2021-10

[6]
Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings.

Diagnostics (Basel). 2021-2-18

[7]
Infant sex modifies associations between placental malaria and risk of malaria in infancy.

Malar J. 2020-12-3

[8]
Placental Malaria.

Curr Trop Med Rep. 2020

本文引用的文献

[1]
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.

Lancet. 2019-3-22

[2]
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem.

Lancet Infect Dis. 2018-1-31

[3]
Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes.

Malar J. 2017-10-5

[4]
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.

N Engl J Med. 2016-3-10

[5]
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015).

Malar J. 2016-2-24

[6]
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.

Lancet. 2015-12-19

[7]
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.

J Infect Dis. 2015-6-15

[8]
Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda.

J Infect Dis. 2013-4-30

[9]
Diagnosing malaria in pregnancy: an update.

Expert Rev Anti Infect Ther. 2012-10

[10]
Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial.

Malar J. 2012-5-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索